The board of directors at Lassogen has a long and varied history, with many members having experience in different industries and levels of education. Some notable previous experiences and education histories of the board members include: being a co-founder at Apros Therapeutics, Inc., being a Senior Research Investigator at GNF, being a Bioassay Analyst at Biogen, being the John and Margaret Witt Professor of Chemistry at University of Illinois at Urbana-Champaign, Hartwell Foundation Postdoctoral Fellow at University of California, San Diego, Graduate Student at UC Berkeley, Undergraduate Researcher at Carnegie Mellon University, Founder & President at Paragon Biotech Consulting LLC, Advisory Board Member at Vast Life Sciences Inc. dba Vastbiome, Advisor - SPARK Translational Research Program at Stanford University, General Counsel at Indigo Ag, Inc., Independent Consultant at Biolucid LLC, Research Manager, Fermentation at Novozymes, Group Leader, Bioprocess Technology at Marrone Bio Innovations, Associate Director, Fermentation at Agrinos, Inc., Chief Medical Officer at Mirati Therapeutics, CHIEF MEDICAL OFFICER at eFFECTOR THERAPEUTICS, VP, Head of Oncology, Biotechnology Clinical Development at Pfizer, Founder and President at JEREMY BARTON CONSULTING INC, Clinical Research Consultant at Mark Hurtt Consulting, Chief Medical Officer at Alseres Phamaceuticals
Andrew Miller
Advisor
David Cheresh
Advisor
Douglas Mitchell
Founder & Advisor
Elaine Stracker
Board Member
Gian Oddone
Advisor
Jeremy Barton
Advisor
Julian Hegemann
Advisor
Mark Hurtt
Advisor
Matthew Lee
Advisor
Mervyn Bibb
Advisor
Phyllis Whiteley
Board Member
Richard Hatley
Advisor
Simon Macdonald
Advisor
Steven Bender
Advisor
Toby Richardson
Advisor
Tracy Handel
Founder & Advisor
View all